论文部分内容阅读
目的分析肝素在治疗妊娠中晚孕脐动脉血流的异常的临床疗效和使用的价值。方法将2011年6月到2012年6月之间我院产科收治的144例妊娠28-32周的脐动脉血流异常的孕妇随机的分为两组,其中观察组72例孕妇采取肝素进行治疗,而对照组72例孕妇采取低分子右旋糖酐和丹参进行治疗,观察两组治疗后的脐动脉血流变化情况。结果通过对比分析,其中观察组治疗后的孕妇脐动脉的血流动力学变化情况明显的好于对照组治疗后的孕妇脐动脉的血流动力学变化情况,比较差异具有显著性(P<0.05),统计学有意义。结论肝素对于妊娠中晚的孕脐动脉血流的异常治疗具有效果的临床显著,而且整个治疗的过程比较短、安全可靠,值得临床中应用推广。
Objective To analyze the clinical efficacy and the value of heparin in treating abnormal umbilical artery blood flow during pregnancy. Methods From June 2011 to June 2012, 144 pregnant women with umbilical artery abnormalities who were admitted to obstetrics and gynecology from 28 to 32 weeks of gestation were randomly divided into two groups. Among them, 72 pregnant women in the observation group were treated with heparin While 72 pregnant women in the control group took low molecular dextran and salvia miltiorrhiza for treatment. The changes of umbilical artery blood flow in both groups were observed. Results Through the comparative analysis, the hemodynamic changes of the umbilical arteries in the observation group were significantly better than those in the control group after umbilical artery treatment, the difference was significant (P <0.05 ), Statistically significant. Conclusions Heparin is clinically significant for the treatment of abnormal umbilical artery blood flow in the middle and late gestational periods, and the whole treatment process is relatively short, safe and reliable, which is worth popularizing in clinic.